Aagaard, C.

Jungersen, Gregers

Lundegaard, Claus

Mikkelsen, Heidi

Olsen, I.

Tollefsen, S.

Paratuberculosis in ruminants is caused by an infection with Mycobacterium avium subspecies paratuberculosis (MAP) and is a chronic disease characterized by granulomatous enteritis. Available vaccines against paratuberculosis consist of variations of whole bacteria with adjuvant showing various efficacies. The main problem with available vaccines is their interference with surveillance and diagnosis of bovine tuberculosis and paratuberculosis. Our ultimate aim is to develop a subunit vaccine consisting of selected MAP peptides, which allow differentiation of infected from vaccinated animals. Here, 118 peptides were identified by in silico analysis and synthesized chemically. Peptides were tested for reactivity and immunogenicity with T-cell lines generated from PBMCs isolated from MAP infected goats and with blood samples from MAP infected calves. Immunogenicity of peptides was evaluated using full blood IFN-γ release assay and ELISPOT measuring IFN-γ release of PBMCs. A number of peptides resulted in high T cell proliferative responses in T-cell lines and some peptides induced IFN-γ production measured by ELISPOT. This indicates that some of the peptides in the panel contain T cell epitopes and are immunogenic. In the near future, a panel of selected peptides will be tested for efficacy as a vaccine against paratuberculosis with calves or goats experimentally infected with MAP

Online Research Database In Technology

                       General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.  • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal   If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.     Downloaded from orbit.dtu.dk on: Dec 20, 2017Immunogenicity of Mycobacterium avium subsp. paratuberculosis specific peptidesfor inclusion in a subunit vaccine against paratuberculosisMelvang, Heidi Mikkelsen; Tollefsen, S.; Olsen, I.; Aagaard, C.; Lundegaard, Claus; Jungersen, GregersPublication date:2012Link back to DTU OrbitCitation (APA):Mikkelsen, H., Tollefsen, S., Olsen, I., Aagaard, C., Lundegaard, C., & Jungersen, G. (2012). Immunogenicity ofMycobacterium avium subsp. paratuberculosis specific peptides for inclusion in a subunit vaccine againstparatuberculosis. Abstract from 4th European Veterinary Immunology Workshop (EVIW), Edinburgh, UnitedKingdom.Immunogenicity of Mycobacterium avium subsp. paratuberculosis specific peptides for inclusion in a subunit vaccine against paratuberculosis H. Mikkelsen1, S. Tollefsen2, I. Olsen2, C. Aagaard3, C. Lundegaard4 and G. Jungersen1 1National Veterinary Institute, Technical University of Denmark, Copenhagen, Denmark; 2 Norwegian Veterinary Institute, Oslo, Norway; 3State Serum Institute; Copenhagen, Denmark and 4Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark. Paratuberculosis in ruminants is caused by an infection with Mycobacterium avium subspecies paratuberculosis (MAP) and is a chronic disease characterized by granulomatous enteritis. Available vaccines against paratuberculosis consist of variations of whole bacteria with adjuvant showing various efficacies. The main problem with available vaccines is their interference with surveillance and diagnosis of bovine tuberculosis and paratuberculosis. Our ultimate aim is to develop a subunit vaccine consisting of selected MAP peptides, which allow differentiation of infected from vaccinated animals.  Here, 118 peptides were identified by in silico analysis and synthesized chemically. Peptides were tested for reactivity and immunogenicity with T-cell lines generated from PBMCs isolated from MAP infected goats and with blood samples from MAP infected calves. Immunogenicity of peptides was evaluated using full blood IFN-γ release assay and ELISPOT measuring IFN-γ release of PBMCs. A number of peptides resulted in high T cell proliferative responses in T-cell lines and some peptides induced IFN-γ production measured by ELISPOT. This indicates that some of the peptides in the panel contain T cell epitopes and are immunogenic. In the near future, a panel of selected peptides will be tested for efficacy as a vaccine against paratuberculosis with calves or goats experimentally infected with MAP.     

Immunogenicity of Mycobacterium avium subsp. paratuberculosis specific peptides for inclusion in a subunit vaccine against paratuberculosis

http://orbit.dtu.dk/ws/files/9859898/Mikkelsen_4EVIG.pdf

Immunogenicity of Mycobacterium avium subsp. paratuberculosis specific peptides for inclusion in a subunit vaccine against paratuberculosis

Abstract

Similar works

Full text

Available Versions

Online Research Database In Technology